Matija Rojnik - Fluicell Chief Officer
| FLUI Stock | SEK 10.40 0.30 2.97% |
Insider
Matija Rojnik is Chief Officer of Fluicell AB
| Age | 39 |
| Phone | 46 7 62 08 33 54 |
| Web | https://www.fluicell.com |
Fluicell Management Efficiency
The company has return on total asset (ROA) of (0.4939) % which means that it has lost $0.4939 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.1298) %, meaning that it generated substantial loss on money invested by shareholders. Fluicell's management efficiency ratios could be used to measure how well Fluicell manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Fredrik Persson | Prostatype Genomics AB | N/A | |
| Peter Gilmour | Guard Therapeutics Internationa | N/A | |
| Niklas Lindecrantz | Chordate Medical Holding | 55 | |
| Mattias MSc | Stayble Therapeutics AB | 44 | |
| Michael Reusch | Guard Therapeutics Internationa | 63 | |
| Helena Thedius | Chordate Medical Holding | 47 | |
| Mark Gray | 2cureX AB | 53 | |
| Joakim Soderin | Prostatype Genomics AB | N/A | |
| Karin Botha | Guard Therapeutics Internationa | 50 | |
| Jan Lindberg | Chordate Medical Holding | 67 | |
| AnnKristin Myde | Guard Therapeutics Internationa | N/A | |
| Andreas MSc | Stayble Therapeutics AB | 35 | |
| Thomas MSc | Stayble Therapeutics AB | 71 | |
| Fredrik Lehmann | Guard Therapeutics Internationa | 43 | |
| Michael Winklerfelt | Prostatype Genomics AB | 51 | |
| Fernando Andreu | 2cureX AB | 59 | |
| Nicklas Rosendal | Prostatype Genomics AB | N/A | |
| Jan Hermansson | Chordate Medical Holding | 67 | |
| Sara Thuresson | Guard Therapeutics Internationa | N/A | |
| Torbjorn Larsson | Guard Therapeutics Internationa | N/A | |
| Anders Weilandt | Chordate Medical Holding | 62 | |
Management Performance
| Return On Equity | -1.13 | |||
| Return On Asset | -0.49 |
Fluicell AB Leadership Team
Elected by the shareholders, the Fluicell's board of directors comprises two types of representatives: Fluicell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fluicell. The board's role is to monitor Fluicell's management team and ensure that shareholders' interests are well served. Fluicell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fluicell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matija Rojnik, Chief Officer | ||
| Tatsiana Lobovkina, Chief Officer | ||
| Mats Jonasson, Chief Officer | ||
| Victoire Viannay, Chief Officer | ||
| Jonas Hannestad, Chief Officer | ||
| Gavin Jeffries, CTO Director |
Fluicell Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Fluicell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.13 | |||
| Return On Asset | -0.49 | |||
| Operating Margin | (8.62) % | |||
| Current Valuation | 49.13 M | |||
| Shares Outstanding | 24.49 M | |||
| Shares Owned By Insiders | 11.20 % | |||
| Shares Owned By Institutions | 0.67 % | |||
| Price To Book | 4.86 X | |||
| Price To Sales | 10.51 X | |||
| Revenue | 2.6 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fluicell Stock Analysis
When running Fluicell's price analysis, check to measure Fluicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluicell is operating at the current time. Most of Fluicell's value examination focuses on studying past and present price action to predict the probability of Fluicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluicell's price. Additionally, you may evaluate how the addition of Fluicell to your portfolios can decrease your overall portfolio volatility.